Amalgamated Bank’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,718
Closed -$368K 3327
2022
Q1
$368K Buy
+19,718
New +$355K ﹤0.01% 1679

Other funds holding OCDX

Amalgamated Bank's OCDX Position: Q2 2022 in Review

Amalgamated Bank sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 19,718 shares — an estimated $368K sold.

Amalgamated Bank first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $368K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Amalgamated Bank reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 19,718 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $368K.
  • Amalgamated Bank first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $368K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.